
Types of Pharmacy Residencies
Students looking to gain practical experience as part of their pharmacy education can take advantage of two types of residency programs through the Leslie Dan Faculty of Pharmacy.
In addition to residency programs, the Leslie Dan Faculty of Pharmacy offers a variety of programs for practicing pharmacists.
Hospital Pharmacy Residency Programs
Hospital Pharmacy residencies in Ontario are co-ordinated by the Pharmacy Residency Forum of Ontario (PRFO). The accredited residency programs follow the standards and guidelines of the Canadian Pharmacy Residency Board (CPRB). Individual programs are affiliated with one of the academic pharmacy programs in Ontario, including the Leslie Dan Faculty of Pharmacy at the University of Toronto. These 12-month learning experiences involve structured rotations in pharmacy practice, education, research, and administration. The goal is to prepare pharmacists for challenging and innovative pharmacy practice careers. The residency year will start between July and September.
For more information and to apply for a hospital residency, please visit the Canadian Society of Hospital Pharmacists site.
For information about a Hospital Pharmacy Residency/MSc Combined Program, please visit the Master of Science in Pharmaceutical Sciences (MSc) site.
Industrial Pharmacy Residency Program
The Industrial Pharmacy Residency Program (IPRP) is administered by the Leslie Dan Faculty of Pharmacy, University of Toronto, in cooperation with participating Pharmaceutical Companies as listed below. These one-year specialty residencies develop skills and provide experience focused within the stated specialty area. This is an educational residency program for graduates from a recognized Pharmacy degree program; it is not an application for a position with a pharmaceutical company.
Applications Process - CLOSED
Applications are now closed for residencies occurring from September 2023 to August 2024. Applications for residencies occurring from September 2024 to August 2025 will open in September 2023.
New this year
Residency offers from individual companies will be communicated to successful applicants starting on February 10, 2023 and no longer align with the Hospital Residency Program timelines.
The Product Development Regulatory residencies with Roche will be 24 months in length. Please review the updated Terms of Reference document for more information.
- Participating Companies
-
- Abbott Laboratories
- Abbvie
- Alexion AstraZeneca
- Amgen
- AstraZeneca
- Bayer
- Biogen
- Boehringer Ingelheim
- Eisai
- Gilead
- GlaxoSmithKline
- Jazz Pharmaceuticals
- Lilly
- Novo Nordisk
- Paladin Labs
- Roche (Medical Strategy and Product Development Regulatory)
- Sanofi
- Seagen
News

Collaboration key to PharmD alum’s success in industrial residency
Grace Gao receives Industrial Pharmacy Residency Program Award to recognize residency leadership and research excellence.
Read More

U of T Pharmacy alum presents at World Health Assembly in Geneva
Representing the International Pharmacy Student Federation, PharmD 2T1 alum Yifan Zhou shares her experience as a presenting delegate at the 75th World Health Assembly.
Read More

Welcome to the 2021-22 Academic Year from Dean Dolovich
Dean Lisa Dolovich welcomes new and returning students to the 2021-22 academic year.
Read More